A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...
Add Yahoo as a preferred source to see more of our stories on Google. Skin cancer is the most common type of cancer in the United States with 5.4 million new cases of the disease reported every year.
A phase II study of binimetinib plus imatinib in patients with unresectable KIT-mutant melanoma. A phase 1/2 study of vusolimogene oderparepvec (RP1) in primary melanoma (mel) to reduce the risk of ...
(RTTNews) - Biofrontera Inc. (BFRI) said the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application for Ameluz topical gel in combination with the RhodoLED red ...
Red light photodynamic therapy (PDT) with 10% aminolevulinic acid (ALA) tamed superficial basal cell carcinoma (BCC) in a phase 3 trial with no new safety concerns. Significantly higher clearance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results